Overactive bladder drug linked to depression


By Australian Hospital + Healthcare Bulletin Staff
Thursday, 06 April, 2017


A recent international study published in The Journal of Clinical Pharmacology found that women who received antimuscarinics as part of treatment for overactive bladder were 38% more likely to be diagnosed with depressive disorder within the next 3 years than those who did not receive antimuscarinics.

“This population-based retrospective cohort study found that use of antimuscarinics was associated with subsequent depressive disorder in women with overactive bladder,” said Li-Ting Kao, senior author of study.

Although antimuscarinics can significantly depress bladder contractions and improve symptoms by blocking muscarinic receptors, studies have found that several unwanted side effects frequently occur when patients with an overactive bladder receive the drugs.

The cognitive effects (including memory loss) of antimuscarinic drugs in elderly patients are well established. One theory for the increased rate of side effects in elderly people is the increased blood-brain barrier permeability that can occur with advanced age and certain comorbidities may facilitate antimuscarinic access to the central nervous system.

Related News

Debunking nursing clichés will attract school leavers

Stereotypes portraying nurses as sexual objects or merely doctors' helpers must be combatted...

Supporting aged-care communication challenges

It is increasingly challenging for aged-care workers, many of whom come from diverse linguistic...

Could the Australian Synchrotron help to find a superbug supercure?

Professor Alice Vrielink is using the Australian Synchrotron to unlock the secrets of...


  • All content Copyright © 2017 Westwick-Farrow Pty Ltd